Dedicating our resources to YOUR Cell Therapy Products & Exosomes

More than a classical…

C D M O A

Analytics-driven

Associate

Accelerator

Qualify your Product before patient injection

- - Cell^feature: Therapeutic performance
  - Cell^nature: Identity
  - Cell^secure: Safety

Learn more

Multi-expertise customized approach

- - From Donor tissue to Patients’ injection
  - Regulatory full support
  - Industrialization-focused strategies

Learn more

Ready to use dedicated Platforms

- - Cell^process Platform : PROCESS
  - Cell^analytics Platform : ANALYTICS
  - MSC4^all Platform : Off-the-Shelf MSCs

Bridging the gap between R&D Project and clinical Development

Our Offer at a glance

From Regenerative Medicine to Immuno-Oncology,

From Autologous strategy to Allogeneic approach,

From primary cells to GMO cells

From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,

YOUR REQUIREMENTS ARE OUR PRIORITIES

YOUR Development stages

iPS Cells

Adult Stem Cells

EV & Exoxomes

Engineered Cells (CAR-T, CAR-NK,…)

Other ATMPs

Discovery

Pre-Clinical Development

Clinical Development

NDA Review & Approval

Ph.I
Ph.II
Ph.III

Post-Market monitoring

Ph.IV

OUR Offer

Regulatory coaching

Supply chain & human tissues sourcing

Process & analytical development

Process & analytical validation

Technical Transfer

R&D manufacturing

cGMP manufacturing

QC release & stability studies

Our partners

THEY TRUST US !

News

Press

18.08.2022

Cell-Easy to participate at Phacilitate Advanced Therapies Europe meeting in London, August 31 – September 1, 2022

Cell-Easy Business Director Guillaume Lay will attend the Advanced Therapies […]

Press

28.02.2022

The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe

Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]

Press

07.02.2022

Virginie Duel joins Cell-Easy as Head of Quality Control.

The Cell-Easy management team is very pleased to announce the […]

View all

Contact

Tel : +33 534 276 550
Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
Mail : info@cell-easy.com

European leading CDMO company specialized in large volume industrialized production of GMP approved cell products